info@birdgroup.be

Login

Papers

United European Gastroenterol J. 2018 Apr;6(3):439-445
Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonists

Inflamm Bowel Dis - Volume 19, Number 10, September 2013
Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy

Journal of Crohn's and Colitis (2013) 7, 154-160
Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn\'s patients

Journal of Crohn's and Colitis (2013) 7, e588-e598
Profile of pediatric Crohn's disease in Belgium

Journal of Crohn's and Colitis (2012) 6, 557-562
Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naÃ¯ve patients with ulcerative colitis

Clinical Biochemistry 44 (2011) 1062-1066
Limitations of extensive TPMT genotyping in the management of azathioprine-induced myelosuppression in IBD patients

Inflamm Bowel Dis - Volume 16, Number 2, February 2010
Efficacy of Infliximab in Refractory Pouchitis and Crohn's Disease-Related Complications of the Pouch: A Belgian Case Series

Gastroenterology 2010; 138:463-468
Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease

‹
1
2
3
4
5
6
›